文献速递脑血管病外科神经重症

L-精氨酸对大鼠血管痉挛的治疗作用:实验研究

Effect of L-Arginine Therapy on Vasospasm: Experimental Study in Rats.
PubMed 文献 · World Neurosurg · 2019-09-05

组织病理分析显示L-精氨酸可减轻弹性膜不规则、内皮细胞破坏等形态学改变,壁厚度和管腔直径测量较痉挛组显著改善(P < 0.01)。作者认为L-精氨酸作为一氧化氮底物可用于蛛网膜下腔出血后脑血管痉挛的防治。

要点

  • L-精氨酸可减轻大鼠实验性血管痉挛的形态学改变。
  • 痉挛+L-精氨酸组壁厚度和管腔直径较痉挛组显著改善(P < 0.01)。
  • L-精氨酸作为一氧化氮底物,可能用于蛛网膜下腔出血后脑血管痉挛的防治。

核心结论

  • L-精氨酸作为一氧化氮底物可改善大鼠实验性血管痉挛,作者认为可用于蛛网膜下腔出血后脑血管痉挛的预防和治疗。

研究设计与样本

  • 采用Okada等描述的大鼠股动脉血管痉挛模型,L-精氨酸组给予300 mg/kg L-精氨酸7天。
  • 处死后取股动脉标本行组织病理学检查,统计学分析采用Kruskal-Wallis和Mann-Whitney U检验,P < 0.05为差异有统计学意义。

主要发现

  • L-精氨酸治疗减轻了血管痉挛引起的弹性膜不规则、内皮细胞破坏、空泡化和出血等形态学改变。
  • 壁厚度和管腔直径测量中,血管痉挛+L-精氨酸组较血管痉挛组显著改善(P < 0.01)。

关键数值与推荐

  • L-精氨酸组剂量为300 mg/kg,给药7天。
  • 壁厚度和管腔直径比较,血管痉挛+L-精氨酸组 vs 血管痉挛组 P < 0.01。

临床怎么用

  • 动物实验提示L-精氨酸可能作为蛛网膜下腔出血后脑血管痉挛的潜在防治手段,尚需临床研究验证。

局限性

  • 仅进行组织病理学分析,未报告临床结局或长期功能结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Cerebral vasospasm occurring after subarachnoid hemorrhage is a serious cause of morbidity. Cerebral vasospasm-related studies aim to prevent complications after subarachnoid hemorrhage. Nitric oxide affects brain blood flow and local vascular hemodynamics. L-arginine is used in the synthesis of nitric oxide, and hence we have investigated the efficacy of L-arginine treatment by using femoral artery vasospasm model. METHODS: Twenty-four male Sprague-Dawley rats have been divided into 3 groups as vasospasm, vasospasm + L-arginine, and control. In this study, we have preferred the "Rat Femoral Artery Vasospasm Model" described by Okada et al. Rats in the vasospasm + L-arginine group were given 300 mg/kg L-arginine for 7 days. At the end of the study, all samples of rat femoral arteries have been dissected and examined microscopically for histopathologic analysis. Statistical analysis was performed using Kruskal-Wallis and Mann-Whitney U tests, and P < 0.05 value was considered statistically significant. RESULTS: L-arginine treatment reduced the morphometric changes such as irregularity of the elastic lamina, disruption of the endothelial cells, vacuolization, and hemorrhages that are caused by vasospasm. When the wall thickness and lumen diameter measurements were evaluated statistically, significant improvement was observed in the vasospasm + L-arginine group compared with the vasospasm group (P < 0.01). CONCLUSIONS: In our study, the use of L-arginine, as a nitric oxide substrate, improved the experimental vasospasm in rats. Therefore we think that L-arginine therapy can be used in the prevention and treatment of cerebral vasospasm after subarachnoid hemorrhage.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Akar E, Emon ST, Uslu S, et al. Effect of L-Arginine Therapy on Vasospasm: Experimental Study in Rats. World Neurosurg. 2019. PMID: 31494312. doi:10.1016/j.wneu.2019.08.119

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。